| __timestamp | Agios Pharmaceuticals, Inc. | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 17268000 |
| Thursday, January 1, 2015 | 35992000 | 19667000 |
| Friday, January 1, 2016 | 50714000 | 27823000 |
| Sunday, January 1, 2017 | 71124000 | 36468000 |
| Monday, January 1, 2018 | 114145000 | 31282000 |
| Tuesday, January 1, 2019 | 132034000 | 39610000 |
| Wednesday, January 1, 2020 | 149070000 | 52820000 |
| Friday, January 1, 2021 | 121445000 | 96803000 |
| Saturday, January 1, 2022 | 121673000 | 177977000 |
| Sunday, January 1, 2023 | 119903000 | 173612000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational expenses is crucial for sustaining innovation. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two prominent biotech companies: Cytokinetics, Incorporated and Agios Pharmaceuticals, Inc., from 2014 to 2023.
Agios Pharmaceuticals has shown a consistent increase in SG&A expenses, peaking in 2020 with a 680% rise from 2014. This trend reflects their aggressive expansion and investment in research and development. In contrast, Cytokinetics, while also increasing their SG&A expenses, demonstrated a more moderate growth of approximately 900% over the same period, with a significant spike in 2022.
The data suggests that both companies are strategically investing in their operational capabilities, albeit at different paces. This insight into their financial strategies provides a glimpse into how these biotech leaders are positioning themselves for future growth and innovation.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Alkermes plc
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.